Pharmaceutical manufacturing takes centre stage on Day three of The Future of Bio/Pharmaceutical Analysis Virtual Summit 2026 as speakers examine how digital technologies, artificial intelligence and advanced production methods are reshaping what is possible in the field.
Giancarlo Benelli reflects on why Europe must capitalise on its strong innovative drug discovery infrastructure by shoring up the last mile and attracting clinical trials back to Europe’s healthcare systems.
CEO of Lupin Manufacturing Solutions, shares his perspective on what differentiates credible CDMO entrants as pharmaceutical pipelines shift towards structurally complex molecules, the scientific imperatives shaping oncology and peptide manufacturing and the talent challenge that he believes will define competitive positioning in the decade ahead.
Hear from Dr Zi Li, Associate Director of Formulation at BioDuro, to explore how polymorph screening, salt formation and cocrystallisation can resolve dissolution, stability and IP challenges in early-stage drug development.
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.